Alpha DNA Investment Management’s Hercules Capital HTGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-77,411
Closed -$998K – 187
2023
Q1
$998K Buy
77,411
+160
+0.2% +$2.24K 0.29% 120
2022
Q4
$1.02M Buy
+77,251
New +$1.05M 0.36% 123

Other funds holding HTGC

Alpha DNA Investment Management's HTGC Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of Hercules Capital (HTGC) in Q2 2023, closing a stake of 77,411 shares — an estimated $998K sold.

Alpha DNA Investment Management first reported a position in HTGC in Q4 2022 and held it in 2 quarters. The position peaked at $1.02M in Q4 2022. 249 funds tracked by Wall St. Rank hold HTGC as of Q2 2023.

  • Alpha DNA Investment Management reported no remaining Hercules Capital position as of Q2 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 77,411 Hercules Capital shares in Q2 2023, an estimated $998K.
  • Alpha DNA Investment Management first reported a position in Hercules Capital in Q4 2022 and held it in 2 quarters.
  • Alpha DNA Investment Management's Hercules Capital position peaked at $1.02M in Q4 2022.
  • 249 funds tracked by Wall St. Rank held Hercules Capital as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.